Legacy Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
51,582
-33
-0.1% -$886 0.17% 73
2026
Q1
$1.07M Sell
51,615
-15
-0% -$354 0.13% 103
2025
Q4
$1.68M Buy
51,630
+30
+0.1% +$1.28K 0.18% 69
2025
Q3
$2.93M Buy
+51,600
New +$2.64M 0.36% 43
2025
Q2
Sell
-31,196
Closed -$922K 186
2025
Q1
$922K Sell
31,196
-5,000
-14% -$186K 0.09% 170
2024
Q4
$875K Hold
36,196
0.08% 181
2024
Q3
$667K Hold
36,196
0.07% 208
2024
Q2
$731K Hold
36,196
0.09% 169
2024
Q1
$560K Buy
36,196
+2,144
+6% +$24.2K 0.07% 196
2023
Q4
$303K Hold
34,052
0.04% 244
2023
Q3
$214K Hold
34,052
0.03% 266
2023
Q2
$320K Hold
34,052
0.05% 215
2023
Q1
$338K Hold
34,052
0.06% 189
2022
Q4
$218K Sell
34,052
-30,000
-47% -$171K 0.04% 225
2022
Q3
$357K Buy
64,052
+32,026
+100% +$193K 0.08% 157
2022
Q2
$145K Hold
32,026
0.03% 211
2022
Q1
$171K Buy
+32,026
New +$158K 0.03% 209

Other funds holding HIMS

Legacy Advisors's HIMS Position: Q2 2026 in Review

Legacy Advisors reduced its Hims & Hers Health (HIMS) stake by 0.06% in Q2 2026, selling an estimated $886 and leaving 51,582 shares worth $1.79M. The position accounts for 0.17% of the portfolio, ranked #73.

Legacy Advisors first reported a position in HIMS in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.93M in Q3 2025. 92 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Legacy Advisors held 51,582 shares of Hims & Hers Health worth $1.79M as of Q2 2026.
  • Legacy Advisors sold 33 Hims & Hers Health shares in Q2 2026, an estimated $886.
  • Hims & Hers Health made up 0.17% of Legacy Advisors's portfolio in Q2 2026, its #73 holding.
  • Legacy Advisors first reported a position in Hims & Hers Health in Q1 2022 and has held it in 17 quarters since.
  • Legacy Advisors's Hims & Hers Health position peaked at $2.93M in Q3 2025.
  • 92 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.